Quana

Decision Support Platform for Medical Cannabis

Health Tech & Life Sciences
Non Active, Jul 2025 ceased to operate
Seed Israel Founded 2018
Last updated 2026-06-18
Total raised
—
Last: Undisclosed Round 2019-07
Stage
Seed
Founded
2018
Headcount
—
HQ
Israel
Sector
Health Tech & Life Sciences

About

Quana is working in collaboration with the Hebrew University of Jerusalem to develop a technology to understand and innovate global cannabis consumption and data and to provide consumers and producers with immediate and personalized decision support for medical cannabis use.

Quana harnesses a special set of sensors, cloud-based big-data algorithms, and a mobile app to detect, analyze, and generate a unique olfactive fingerprint for each cannabis sample without harming the sample.

The company’s platform identifies and alerts users and producers to the presence of molds and pesticides while also personalizing cannabinoid consumption through the use of decision-making algorithms that match the most suitable cannabis product to the consumer’s needs.

Offices

Israel · HQ / main office

Q&A

What is Quana's primary focus?
Quana is developing a decision support platform for medical cannabis, aiming to provide consumers and producers with personalized recommendations and data insights.
When was Quana founded?
Quana was founded in April 2018.
What is the current status of Quana?
Quana is currently inactive, having ceased operations in July 2025.
How much funding has Quana raised in total?
Quana has raised a total of $460,000.
When was Quana's last funding round?
Quana's last funding round occurred in July 2019, raising $460,000.
What technology does Quana utilize in its platform?
Quana's platform utilizes sensors, cloud-based big-data algorithms, and a mobile app to detect, analyze, and generate unique olfactive fingerprints for cannabis samples.
What problem does Quana's platform aim to solve for users?
Quana's platform aims to identify and alert users to the presence of molds and pesticides in cannabis, and to personalize cannabinoid consumption by matching suitable products to consumer needs.
Who are the co-founders of Quana?
The co-founders of Quana are Adi Naali (Co-founder & CEO) and Zohar Kerem (Co-founder & Chief Scientist).

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
CommunicationsIOTData StorageCloudArtificial IntelligenceMachine LearningSensingScentPlatforms & InterfacesMobile
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsConsumersRecreational & LifestyleCannabis
Business model
B2B

Highlights

1 PatentsVerified

Tags

machine-learningmedical-cannabispersonalizationcloudpharma-companieshealthcare-providersartificial-intelligencesensorsretailersmobile-applicationsalgorithmsrecommendationsdata-analyticsconsumerscannabismedical-technologiesconsumer-electronicsbig-datanon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)